Park Sang Hee, Lee Bomyee, Lee Sangeun, Choi Eunji, Choi Eun-Bi, Yoo Jisu, Jun Jae Kwan, Choi Kui Son
Graduate School of Communication, Sogang University, 35 Baekbeom-ro, Mapo-gu, Seoul, 121-742, Republic of Korea.
National Cancer Control Institute, National Cancer Centre, 323, Ilsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 410-769, Republic of Korea.
BMC Cancer. 2015 Nov 6;15:858. doi: 10.1186/s12885-015-1877-6.
The incidence of thyroid cancer in Korea has increased by about 25 % every year for the past 10 years. This increase is largely due to a rising incidence in papillary thyroid cancer, which is associated with an overdiagnosis of small tumors that may never become clinically significant. This study was conducted to explore Korean women's understanding of overdiagnosis and to investigate changes in screening intention in response to overdiagnosis information.
Focus group interviews were conducted among women of ages 30-69 years, who are commonly targeted in Korea for cancer screening. Women were divided into four groups according to thyroid cancer screening history and history of thyroid disease. Of 51 women who were contacted, 29 (57 %) participated in the interviews.
Prior awareness of thyroid cancer overdiagnosis was minimal. When informed about the risks of overdiagnosis, the participants were often surprised. Overcoming initial malcontent, many women remained skeptic about overdiagnosis and trusted in the advice of their physicians. Meanwhile, some of the study participants found explanations of overdiagnosis difficult to understand. Further, hearing about the risks of overdiagnosis had limited impact on the participants' attitudes and intentions to undergo thyroid cancer screening, as many women expressed willingness to undergoing continued screening in the future.
A large majority of Korean women eligible for and had undergone thyroid cancer screening were unaware of the potential for overdiagnosis. Nevertheless, overdiagnosis information generally had little impact on their beliefs about thyroid cancer screening and their intentions to undergo future screening. Further research is needed to determine whether these findings could be generalized to the wider Korean population.
在过去10年中,韩国甲状腺癌的发病率每年增长约25%。这种增长主要归因于乳头状甲状腺癌发病率的上升,这与小肿瘤的过度诊断有关,而这些小肿瘤可能永远不会发展为具有临床意义的疾病。本研究旨在探讨韩国女性对过度诊断的理解,并调查她们在得知过度诊断信息后筛查意愿的变化。
对年龄在30 - 69岁的女性进行焦点小组访谈,这些女性通常是韩国癌症筛查的目标人群。根据甲状腺癌筛查史和甲状腺疾病史将女性分为四组。在联系的51名女性中,29名(57%)参与了访谈。
对甲状腺癌过度诊断的先前认知极少。当被告知过度诊断的风险时,参与者常常感到惊讶。克服最初的不满情绪后,许多女性对过度诊断仍持怀疑态度,并信任医生的建议。与此同时,一些研究参与者觉得对过度诊断的解释难以理解。此外,得知过度诊断的风险对参与者接受甲状腺癌筛查的态度和意愿影响有限,因为许多女性表示愿意在未来继续接受筛查。
绝大多数符合条件且已接受甲状腺癌筛查的韩国女性并未意识到存在过度诊断的可能性。然而,过度诊断信息总体上对她们关于甲状腺癌筛查的信念以及未来接受筛查的意愿影响不大。需要进一步研究以确定这些发现是否能推广至更广泛的韩国人群。